Related Experiment Video
Updated: Jun 20, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Characterization of a novel human CDK5 splicing variant that inhibits Wnt/beta-catenin signaling
Qiang Li1, Xianghua Liu, Mingjun Zhang
1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, 200433 Shanghai, People's Republic of China. lq054@hotmail.com
Abstract:
The cyclin-dependent kinases (CDKs) are a family of serine/threonine kinases, playing an essential role in regulating cell-cycle progression. In our present work, human CDK5 and a novel CDK5 splicing variant, named as CDK5-SV, were cloned from the cDNA library of human testis. CDK5-SV lacking the exon 7 of CDK5 encodes a protein of 260 amino acids. Through RT-PCR analysis in different human tissues, CDK5-SV was found to be expressed in testis, skeletal muscle, colon, bone marrow and ovary, while CDK5 was ubiquitously expressed. Immunofluorescence experiment in HeLa cells showed that the subcellular localizations of CDK5-SV and CDK5 were totally different. CDK5 mainly located in the cytoplasm, while CDK5-SV accumulated in nucleus. Reporter gene assay showed that when co-transfected with beta-catenin, CDK5 and CDK5-SV could both strongly inhibit the Wnt/beta-catenin signaling pathway. Consistently, CDK5-SV could also interact with beta-catenin as CDK5 does. Taken together, our findings suggest that CDK5-SV might also be a negative regulator of Wnt/beta-catenin signaling pathway.
Insights
A novel cyclin-dependent kinase 5 splicing variant (CDK5-SV) was identified. CDK5-SV, like CDK5, inhibits the Wnt/beta-catenin pathway, suggesting its role as a negative regulator.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cyclin-dependent kinases (CDKs) regulate cell-cycle progression.
- CDK5 is a key serine/threonine kinase involved in cell cycle regulation.
Purpose of the Study:
- To clone and characterize a novel CDK5 splicing variant (CDK5-SV).
- To investigate the expression, localization, and function of CDK5-SV.
- To determine the role of CDK5-SV in the Wnt/beta-catenin signaling pathway.
Main Methods:
- Cloning of human CDK5 and CDK5-SV from a human testis cDNA library.
- RT-PCR analysis for tissue-specific expression.
- Immunofluorescence microscopy for subcellular localization.
- Reporter gene assays to assess Wnt/beta-catenin signaling inhibition.
- Co-transfection assays to study protein interactions.
Main Results:
- CDK5-SV, a 260-amino acid protein lacking exon 7, was identified.
- CDK5-SV expression is detected in testis, skeletal muscle, colon, bone marrow, and ovary.
- CDK5-SV localizes to the nucleus, distinct from cytoplasmic CDK5.
- Both CDK5 and CDK5-SV inhibit Wnt/beta-catenin signaling and interact with beta-catenin.
Conclusions:
- CDK5-SV is a novel splicing variant of CDK5 with distinct tissue expression and subcellular localization.
- CDK5-SV functions as a negative regulator of the Wnt/beta-catenin signaling pathway, similar to CDK5.
- These findings highlight a new regulatory mechanism within the Wnt/beta-catenin pathway.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Inhibition of Cdk Activity
